Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Rating of "Hold" from Brokerages

Key Points

• Health Catalyst, Inc. (NASDAQ:HCAT) has received a consensus rating of "Hold" from eleven brokerages, with eight analysts recommending holding the stock and three issuing buy recommendations.
• The average 1-year price target for Health Catalyst among analysts is $4.73, with varying recent adjustments from research firms, including Evercore ISI and BTIG Research.
• Shares of Health Catalyst were down 4.3%, currently trading at approximately $2.89, reflecting its market capitalization of $203.37 million.

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $4.7273.

Several research firms have weighed in on HCAT. Evercore ISI raised their price target on Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a report on Thursday, August 28th. BTIG Research restated a "neutral" rating on shares of Health Catalyst in a report on Friday, September 5th. Stifel Nicolaus cut their price target on Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a report on Friday, August 8th. Canaccord Genuity Group cut their price target on Health Catalyst from $9.00 to $5.00 and set a "buy" rating for the company in a report on Friday, August 29th. Finally, Wells Fargo & Company cut their price target on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a report on Monday, August 11th.

Health Catalyst Stock Down 4.3%

Shares of HCAT opened at $2.89 on Friday. The company has a market capitalization of $203.37 million, a PE ratio of -1.91 and a beta of 1.53. The business's 50 day moving average is $3.41 and its 200 day moving average is $3.81. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. Health Catalyst has a 12-month low of $2.52 and a 12-month high of $9.24.

Hedge Funds Weigh In On Health Catalyst

Several institutional investors have recently added to or reduced their stakes in HCAT. Engineers Gate Manager LP boosted its holdings in shares of Health Catalyst by 43.0% in the 2nd quarter. Engineers Gate Manager LP now owns 99,240 shares of the company's stock worth $374,000 after purchasing an additional 29,865 shares during the period. First Light Asset Management LLC boosted its holdings in shares of Health Catalyst by 17.2% in the 2nd quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company's stock worth $46,108,000 after purchasing an additional 1,793,374 shares during the period. Jane Street Group LLC purchased a new position in shares of Health Catalyst in the 2nd quarter worth approximately $173,000. The Manufacturers Life Insurance Company boosted its holdings in shares of Health Catalyst by 19.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 26,491 shares of the company's stock worth $100,000 after purchasing an additional 4,341 shares during the period. Finally, Qube Research & Technologies Ltd boosted its holdings in shares of Health Catalyst by 68.4% in the 2nd quarter. Qube Research & Technologies Ltd now owns 282,281 shares of the company's stock worth $1,064,000 after purchasing an additional 114,626 shares during the period. Hedge funds and other institutional investors own 85.00% of the company's stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.